|
Status |
Public on Sep 22, 2020 |
Title |
RNA_C2C12_deltapro#3_day0_rep3 |
Sample type |
SRA |
|
|
Source name |
C2C12 myoblasts
|
Organism |
Mus musculus |
Characteristics |
time course: day0 treatment: none cell line: C2C12 cell type: myoblasts
|
Treatment protocol |
At the confluence, cells were treated for 48 hours in medium containing 10% FBS, 0.5mM isobuylmethylxanthine, 125nM indomethacin, 1 μM dexamethosone, 850nM insulin, 1nM T3 and 1 μM rosiglitazone. After 48 hours, cells were switched to medium containing 10% FBS, 850nM insulin, 1nM T3 and 1 μM rosiglitazone.
|
Growth protocol |
C2C12 myoblasts were mainteined in Dulbecco’s modified Eagle’s medium containing 10% fetal bovine serum and 1% penicillin/streptomycin.
|
Extracted molecule |
polyA RNA |
Extraction protocol |
Total RNA was extracted using Trizol reagent (Life Techologies) and RNeasy Mini Kit (Qiagen). Libraries were prepared using TruSeq Stranded mRNA Library Prep Kit (Illumina) according to the manufacturer's instructions.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2500 |
|
|
Data processing |
Sequence reads were aligned to the mm9 genome assembly using STAR version 2.5.3a with the following parameters --runThreadN 10 --outSAMtype BAM SortedByCoordinate --quantMode TranscriptomeSAM GeneCounts --limitBAMsortRAM 16000000000 --genomeDir MMUC --readFilesIn Read1.fastq Read2.fastq --outFilterMultimapNmax 1 Read counts for each gene were derived from the STAR output file named "ReadsPerGene.out.tab" and the matched strand count was used for further processes. Genome_build: mm9 Supplementary_files_format_and_content: txt files showing FPKM value of each samples .
|
|
|
Submission date |
Apr 26, 2019 |
Last update date |
Sep 22, 2020 |
Contact name |
Hironori Waki |
E-mail(s) |
[email protected]
|
Organization name |
The University of Tokyo
|
Street address |
Hongo 7-3-1, Bunkyo-ku
|
City |
Tokyo |
ZIP/Postal code |
1138655 |
Country |
Japan |
|
|
Platform ID |
GPL17021 |
Series (2) |
GSE130389 |
NFIA differentially controls adipogenic and myogenic gene program through distinct pathways to ensure adipocyte differentiation [RNA-seq] |
GSE130390 |
NFIA differentially controls adipogenic and myogenic gene program through distinct pathways to ensure adipocyte differentiation |
|
Relations |
BioSample |
SAMN11518887 |
SRA |
SRX5759164 |